India’s economic performance continues to draw global attention as it navigates a complex mix of domestic dynamism and external volatility. In a world marked by slowing global demand, rising trade tensions, shifting monetary policies, and geopolitical risks, the outlook for India’s economy carries implications for…
In the ongoing cycle of corporate earnings announcements, investors, analysts, and executives…
The Indian pharmaceutical industry has long been recognized as a global powerhouse…
Lupin Ltd
Lupin Ltd’s strategic acquisitions in recent years have significantly reshaped its global footprint and competitive positioning in the pharmaceutical industry. Through targeted purchases of…
Lupin Ltd’s Q4 earnings announcement is a closely watched event for investors,…
Lupin Ltd, one of India’s foremost pharmaceutical companies, has taken a major…
Lupin Ltd’s announcement of a new drug approval in the United States…
Lupin Ltd’s announcement of a new drug approval in the United States…
Pharma News
Who funds criticism of the ultra-processed food definition? A new study finds industry links in most critical papers and calls for clearer disclosure.
Business News
Malta, New York is at the centre of a $21 billion semiconductor story. How the GlobalFoundries expansion could reshape supply, work and regional growth.
Search
Recent Posts
Latest Posts
Lupin Ltd’s strategic acquisitions in recent years have significantly reshaped its global footprint and competitive…
Lupin Ltd’s Q4 earnings announcement is a closely watched event for investors, analysts, and anyone…
Lupin Ltd, one of India’s foremost pharmaceutical companies, has taken a major step forward by…
Lupin Ltd’s announcement of a new drug approval in the United States market marks a…
Lupin Ltd’s share price witnessed a sharp upswing after the company reported robust Q3 results,…